Table 3Body of evidence for subcutaneous immunotherapy for asthma plus rhinitis/rhinoconjunctivitis symptom scores

StudyAllergenComparatorNumber of ParticipantsRisk of BiasDirection of ChangeDirectnessMagnitude of Effect
Ariano 200639ParietariaSCIT
Pharmacotherapy
30High+DirectStrong
Arvidsson 2002/200489BirchSCIT
Placebo
49Medium+DirectCould not determine*
Horst 198995AlternariaSCIT
Placebo
24Low+DirectCould not determine*
Nouri-Aria, 2003101TimothySCIT
Placebo
44Low+DirectModerate
Varney 1997110CatSCIT
Placebo
28Medium+DirectStrong

+ = positive; SCIT = subcutaneous immunotherapy

*

Not enough data were provided in the article to calculate the magnitude of effect.

Not enough data were provided in the article to calculate the magnitude of effect.

From: Results

Cover of Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review
Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review [Internet].
Comparative Effectiveness Reviews, No. 111.
Lin SY, Erekosima N, Suarez-Cuervo C, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.